Results of Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases
- 29 March 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (6) , 1661-1669
Abstract
Although hepatic artery infusion chemotherapy (HAIC) of floxuridine (FUDR) for colorectal liver metastases (CLM) can produce high response rates, data concerning preoperative HAIC are scarce. The aim of this study was to assess the feasibility and results of liver resection after preoperative HAIC with FUDR. Between 1995 and 2004, 239 patients with isolated CLM received HAIC in our institution. Fifty of these patients underwent subsequent curative liver resection (HAIC group). Short- and long-term results of the HAIC group were compared with the outcomes of 50 patients who underwent liver resection for CLM without preoperative chemotherapy. Postoperative morbidity rate were comparable between the two groups. Overall disease-free survival at 1 and 3 years after hepatectomy were 77.5% and 57.5% in the HAIC group and 62.9% and 37% in the control group (P = .036). Overall survival from diagnosis of CLM at 1, 3, and 5 years were 97%, 59%, and 49% in the HAIC group versus 94%, 48%, and 35% in the control group (P = .097). When patients were stratified according to clinical-risk scoring (CRS) system, patients with more advanced disease at the time of liver resection (CRS ≥3) had a median survival of 41 months in the HAIC group (n = 37) and 35 months in the control group (n = 34) (P = .031). HAIC of FUDR does not negatively affect the outcome of subsequent liver resection. Preoperative HAIC of FUDR may reduce liver recurrence rate and improve long-term survival in patients with more advanced liver disease.Keywords
This publication has 28 references indexed in Scilit:
- A risk score for predicting perioperative blood transfusion in liver surgeryBritish Journal of Surgery, 2007
- Towards a pan-European consensus on the treatment of patients with colorectal liver metastasesEuropean Journal of Cancer, 2006
- “Technological” Approach Versus Clamp Crushing Technique for Hepatic Parenchymal Transection: A Comparative StudyJournal of Gastrointestinal Surgery, 2006
- Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481)Journal of Clinical Oncology, 2006
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Neoadjuvant Chemotherapy for Metastatic Colon Cancer: A Cautionary NoteJournal of Clinical Oncology, 2005
- Hepatic Arterial Oxaliplatin Infusion Plus Intravenous Chemotherapy in Colorectal Cancer With Inoperable Hepatic Metastases: A Trial of the Gastrointestinal Group of the Fédération Nationale des Centres de Lutte Contre le CancerJournal of Clinical Oncology, 2005
- Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal CarcinomaJournal of Clinical Oncology, 2005
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994